Reminders About Financial Conflicts of Interest and Other Support
A recent study from the HHS Office of Inspector General (OIG) affirmed that NIHÂ grant recipients play a key role in protecting the integrity and security of U.S. biomedical research, in part through requiring Investigators to disclose all of their significant financial interests and all sources of their other support. As noted by the OIG, failures by some recipients to disclose substantial contributions of resources from foreign entities (including foreign governments) have raised concerns about threats to the integrity of NIH-supported research. In response to the OIG recommendations, we are reminding grant applicants a...
Source: NIH Extramural Nexus - September 16, 2022 Category: Research Authors: Mike Lauer Tags: blog Open Mike FCOI other support Research integrity Source Type: funding
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-23-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models foc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2022 Category: Research Source Type: funding
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-23-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models foc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2022 Category: Research Source Type: funding
Technical and Business Assistance (TABA) Consulting Services for National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees
Notice NOT-OD-22-201 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 18, 2022 Category: Research Source Type: funding
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional)
Funding Opportunity RFA-AG-23-029 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Research and Entrepreneurial Development Immersion (REDI) Small Business Innovation Research (SBIR) Grant applications. The goal of this FOA is to foster the career development of early-career scientists with an interest in entrepreneurship by simultaneously supporting their entrepreneurial development and facilitating their transition to industry. This FOA utilizes the R43/R44 Industry Development Award to provide small business concerns (SBCs) the opportunity to support the hiring and sala...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 6, 2022 Category: Research Source Type: funding
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)
Funding Opportunity RFA-AG-23-030 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Research and Entrepreneurial Development Immersion (REDI) Small Business Technology Transfer Research (STTR) Grant applications. The goal of this FOA is to foster the career development of early-career scientists with an interest in entrepreneurship by simultaneously supporting their entrepreneurial development and facilitating their transition to industry. This FOA utilizes the R41/R42 Industry Development Award to provide small business concerns (SBCs) the opportunity to support the hiring...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 6, 2022 Category: Research Source Type: funding
New Approaches for Incorporating Genetic Diversity into Toxicity Testing (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-22-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Phase I (R43), Phase II (R44), Direct to Phase II (R44), and Fast Track (R44) Small Business Innovative Research (SBIR) grant applications from small businesses concerns (SBCs) to develop resources and approaches, including panels of cells or model organisms, that reflect the variability in human populations in chemical toxicity testing . Current toxicology testing is often limited to studies conducted in a small number of laboratory rodent strains, which can fail to identify clinically rel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 30, 2022 Category: Research Source Type: funding
Notice of Change in Required Registrations for PA-22-176 "PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)"
Notice NOT-OD-22-163 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 29, 2022 Category: Research Source Type: funding
Notice of Change in Required Registrations for PA-22-177 "PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"
Notice NOT-OD-22-162 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 29, 2022 Category: Research Source Type: funding
Notice of Change in Required Registrations for PA-22-179 "PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)"
Notice NOT-OD-22-161 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 29, 2022 Category: Research Source Type: funding
Notice of Change in Required Registrations for PA-22-178 "PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)"
Notice NOT-OD-22-164 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 29, 2022 Category: Research Source Type: funding
Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 - Clinical Trials Not Allowed)
Funding Opportunity RFA-DA-23-017 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks grant applications from small business concerns (SBCs) to develop psychoplastogenic compounds and related models for drug discovery and drug development for Substance Use Disorders (SUD), excluding alcohol use disorder. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 24, 2022 Category: Research Source Type: funding
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Funding Opportunity PAS-22-196 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to the National Institute on Aging's (NIA) Small Business Innovation Research (SBIR) program. The aim of this FOA is to support research that may lead to the development of innovative products and/or services that have the potential to advance progress in preventing and treating Alzheimer's disease (AD) and AD-related dementias (ADRD) and/or caring for and treating patients living with AD/ADRD. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 21, 2022 Category: Research Source Type: funding
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Funding Opportunity PAS-22-197 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to the National Institute on Aging's (NIA) Small Business Technology Transfer Research (STTR) program. The aim of this FOA is to support research that may lead to the development of innovative products and/or services with the potential to advance progress in preventing and treating Alzheimer's disease (AD) and AD-related dementias (ADRD) and/or caring for and treating patients living with AD/ADRD. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 21, 2022 Category: Research Source Type: funding
Updated Policy on SBIR/STTR Organization Eligibility in Cases of Legal Action that Changes Small Business Status
Notice NOT-OD-22-143 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 13, 2022 Category: Research Source Type: funding
